Balancing the Risks and Benefits of Benzodiazepines
Matthew E. Hirschtritt, Mark Olfson, Kurt Kroenke
Abstract
Following a September 2020 FDA announcement of a boxed warning for benzodiazepines, this Viewpoint reviews the relative benefits and risks of the drugs to reduce overuse in at-risk patients, moderate underuse in clinically appropriate instances, and guide judicious, rational prescribing.
Topics & Concepts
MedicineIntensive care medicineMEDLINERisk analysis (engineering)Medical emergencyPolitical scienceLawPharmaceutical Practices and Patient OutcomesSleep and related disordersAnesthesia and Sedative Agents